The Bispecific Antibodies Market is experiencing significant growth driven by increasing research and development activities in the field of immuno-oncology. The rising prevalence of cancer and autoimmune diseases is also contributing to the market growth. Additionally, the growing adoption of bispecific antibodies in targeted therapy and personalized medicine is expected to fuel market expansion.
Industry
Report Coverage | Details |
---|---|
Segments Covered | Indication |
Regions Covered | • North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA) |
Company Profiled | Amgen, Roche, Genentech, Akeso,, Janssen, Taisho Pharmaceutical, Immunocore |
High costs associated with the development and production of bispecific antibodies pose a major restraint to market growth. The complexity of manufacturing processes and regulatory challenges are also hindering the market growth potential. Despite the promising benefits of bispecific antibodies, these restraints are impeding the overall market progression.